Reshma Kewalramani

TL;DR: The use of darbepoetin alfa in patients with diabetes, chronic kidney disease, and moderate anemia who were not undergoing dialysis did not reduce the risk of either of the two primary composite outcomes (either death or a cardiovascular event ordeath or a renal event) and was associated with an increased risk of stroke.

TL;DR: Among patients receiving hemodialysis with moderate to severe secondary hyperparathyroidism, the use of etelcalcetide was not inferior to cinacalcet in reducing serum PTH concentrations over 26 weeks; it also met superiority criteria.

TL;DR: In this article, the authors evaluated the relative efficacy and safety of IV calcimimimetic etelcalcetide and the oral calcimlimimetic cinacalcet.

TL;DR: Measurement of troponin T and NT-pro-BNP may improve the identification of patients with CKD who are likely to require renal replacement therapy, supporting a link between cardiac injury and the development of ESRD.

TL;DR: It is concluded that PTA is prevalent and undertreated in KTR, and female gender and lower renal function were associated with lower HCT (both P < 0.001).